Literature DB >> 6325234

Photoaffinity labelling of Ca2+ channels with [3H]azidopine.

D R Ferry, M Rombush, A Goll, H Glossmann.   

Abstract

A 1,4-dihydroypyridine arylazide photoaffinity ligand, [3H]azidopine (50.6 Ci/mmol), has been synthesized. [3H]Azidopine binds reversibly with a Kd of 350 pM to guinea-pig skeletal muscle membranes in the absence of ultraviolet light. The reversible [3H]azidopine binding is inhibited steroselectively by 1,4-dihydropyridines, phenylalkylamine Ca2+ channel blockers and La3+. Covalent incorporation into membrane proteins after photolysis was investigated by sodium dodecyl sulfate polyacrylamide slab gel electrophoresis. [3H]Azidopine is photoincorporated specifically into a protein of Mr approximately 145 000. The covalent labelling of the Mr approximately 145 000 band is inhibited stereoselectively by drugs and cations which block the reversible [3H]azidopine binding. It is suggested that [3H]azidopine is photoincorporated into a subunit of the putative Ca2+ channel.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325234     DOI: 10.1016/0014-5793(84)80299-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  The molecular pharmacology and structural features of calcium channels.

Authors:  D R Ferry; A Goll; M Rombusch; H Glossmann
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 2.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

3.  Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.

Authors:  D R Ferry; A Goll; H Glossmann
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.

Authors:  M Takahashi; M J Seagar; J F Jones; B F Reber; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Purification and affinity labeling of dihydropyridine receptor from rabbit skeletal muscle membranes.

Authors:  U Kanngiesser; P Nalik; O Pongs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 6.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

7.  Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.

Authors:  G H Hockerman; B Z Peterson; E Sharp; T N Tanada; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.

Authors:  K P Campbell; A Sharp; M Strom; S D Kahl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 9.  The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC).

Authors:  M W McEnery
Journal:  J Bioenerg Biomembr       Date:  1992-02       Impact factor: 2.945

10.  A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.

Authors:  G Zernig; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.